The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of BrUOG 354: A randomized phase II trial of nivolumab alone or in combination with ipilimumab for people with ovarian and other extra-renal clear cell carcinomas.
 
Don S. Dizon
Stock and Other Ownership Interests - Doximity; Midi
Honoraria - UpToDate
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Pfizer
Research Funding - Bristol-Myers Squibb (Inst)
Other Relationship - Global Cancer Institute
 
Cara Amanda Mathews
Research Funding - AADI (Inst); Artios (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); avenge bio (Inst); Deciphera (Inst); Elucida Oncology (Inst); EMD Serono (Inst); Genmab (Inst); Immunogen (Inst); Laekna Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (Inst); Seagen (Inst); Tesaro/GSK (Inst); Volastra Therapeutics (Inst); Zentalis (Inst)
 
Shannon MacLaughlan David
No Relationships to Disclose
 
Jason T Machan
No Relationships to Disclose
 
Matthew James Hadfield
No Relationships to Disclose
 
Eric I Marks
Honoraria - Brand Institute; M3; Medscape; Sermo
Research Funding - Merck
 
Rani Bansal
No Relationships to Disclose
 
Christine McGinn
No Relationships to Disclose
 
Faith Hassinger
Employment - Rhode Island Hospital
Research Funding - Rhode Island Hospital (Inst)
 
Denise Luppe
No Relationships to Disclose
 
Janine Grigelevich
No Relationships to Disclose
 
Kelly A Mitchell
No Relationships to Disclose
 
Adam Braga
No Relationships to Disclose
 
Ashlee Sturtevant
No Relationships to Disclose
 
Roxanne Wood
No Relationships to Disclose
 
Ursula A. Matulonis
Honoraria - Alkermes; Symphogen
Consulting or Advisory Role - Agenus; Allarity Therapeutics; Blueprint Medicines; Boehringer Ingelheim; Curelab Oncology; Eisai; GlaxoSmithKline; GlaxoSmithKline; Immunogen; Lilly; Merck; NextCure; ProfoundBio; Tango Therapeutics
Speakers' Bureau - Med Learning Group
Research Funding - Fujifilm; Immunogen; Leap Therapeutics; Merck; Mersana; Novartis; SQZ Biotech; Syndax; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Immunogen
 
Alexi A. Wright
Stock and Other Ownership Interests - Microsoft
Consulting or Advisory Role - Cancer Support Community; GlaxoSmithKline; Merck
Research Funding - NCCN/AstraZeneca (Inst); Pack Health (Inst)
 
Susana M. Campos
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Merck; Novartis
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline
 
Michael J. Birrer
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Merck